Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...
Q1 2026 earnings call recap: guidance reaffirmed but pressured by U.S. pricing; GLP-1 partnerships grow and China recovery eyed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results